SciSparc SPRC
NASDAQ SPRC
$6.68 -0.05 (-0.82%)
As of: Aug 21, 2026 · 2:11 PM EDT

SciSparc (SPRC) Other Non-Current Liabilities (2019 - 2025)

SciSparc (SPRC) posted Other Non-Current Liabilities of $5.2 million for Q4 2025, little changed sequentially from $5.2 million in Q2 2025, and little changed YoY from $5.2 million in Q4 2024.

SciSparc (SPRC) Other Non-Current Liabilities (2019 - 2025) Analysis & Trends

SciSparc has reported Other Non-Current Liabilities for 7 years, with the latest figure at $5.2 million in Q4 2025.

  • Quarterly Other Non-Current Liabilities changed 0.0% year-over-year to $5.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.2 million (changed 0.0% YoY) and the FY2025 annual result came in at $5.2 million, changed 0.0% from the prior year.
  • Other Non-Current Liabilities was little changed at $5.2 million in Q4 2025 per SPRC's latest filing, from $5.2 million in the prior quarter.
  • Over five years, Other Non-Current Liabilities peaked at $10.3 million in Q2 2022 and troughed at $497000.0 in Q3 2022.
  • A 5-year average of $5.3 million and a median of $5.2 million in 2021 frame the typical range for Other Non-Current Liabilities.
  • The sharpest annual moves came in 2021 and 2023: Other Non-Current Liabilities surged 946.15% in 2021, then sank 49.38% in 2023.
  • Over 5 years, Other Non-Current Liabilities stood at $5.2 million in 2021, then changed by 0.0% to $5.2 million in 2022, then changed by 0.0% to $5.2 million in 2023, then changed by 0.0% to $5.2 million in 2024, then changed by 0.0% to $5.2 million in 2025.
  • According to Business Quant data, Other Non-Current Liabilities over the past three periods registered $5.2 million, $5.2 million, and $5.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.71 Bn 130.86 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.60 Bn 77.60 Bn 3.93 Bn
3 Argenx Se 64.82 Bn 59.63 Bn 1.37 Bn
4 Moderna 57.92 Bn 52.79 Bn 52.00 Mn
5 BeOne Medicines 41.88 Bn 36.78 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.46 Bn 28.15 Bn 992.69 Mn
7 BioNTech SE 27.96 Bn 9.57 Bn 668.28 Mn
8 Insmed 27.35 Bn 26.19 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 SciSparc 830,176.72 830,176.72 -

Historic Data

Download Data
DateValue
Dec 31, 2025 5.19 Mn
Jun 30, 2025 5.19 Mn
Dec 31, 2024 5.19 Mn
Jun 30, 2024 5.19 Mn
Dec 31, 2023 5.19 Mn
Jun 30, 2023 5.19 Mn
Dec 31, 2022 5.19 Mn
Sep 30, 2022 497,000.00
Jun 30, 2022 10.25 Mn
Dec 31, 2021 5.19 Mn
Jun 30, 2021 6.26 Mn
Dec 31, 2020 2.21 Mn
Jun 30, 2020 598,000.00
Dec 31, 2019 7,000.00
Jun 30, 2019 486,000.00